Literature DB >> 8105477

Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis.

B A Mock1, M M Krall, J K Dosik.   

Abstract

Plasmacytomas (PCTs) were induced in 47% of BALB/cAnPt mice by the intraperitoneal injection of pristane, in 2% of (BALB/c x DBA/2N)F1, and in 11% of 773 BALB/cAnPt x (BALB/cAnPt x DBA/2N)F1 N2 backcross mice. This result indicates a multigenic mode of inheritance for PCT susceptibility. To locate genes controlling this complex genetic trait, tumor susceptibility in backcross progeny generated from BALB/c and DBA/2N (resistant) mice was correlated with alleles of 83 marker loci. The genotypes of the PCT-susceptible progeny displayed an excess homozygosity for BALB/c alleles within a 32-centimorgan stretch of mouse chromosome 4 (> 95% probability of linkage) with minimal recombination (12%) near Gt10. Another susceptibility gene on mouse chromosome 1 may be linked to Fcgr2 (90% probability of linkage); there were excess heterozygotes for Fcgr2 among the susceptible progeny and excess homozygotes among the resistant progeny. Regions of mouse chromosomes 4 and 1 that are correlated with PCT susceptibility share extensive linkage homology with regions of human chromosome 1 that have been associated with cytogenetic abnormalities in multiple myeloma and lymphoid, breast, and endocrine tumors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8105477      PMCID: PMC47596          DOI: 10.1073/pnas.90.20.9499

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  53 in total

1.  Induction of plasma-cell neoplasms and fibrosarcomas in BALB/c mice carrying diffusion chambers.

Authors:  R M MERWIN; G H ALGIRE
Journal:  Proc Soc Exp Biol Med       Date:  1959-07

Review 2.  Mouse chromosome 4.

Authors:  C M Abbott; R Blank; J T Eppig; J M Friedman; K E Huppi; I Jackson; B A Mock; J Stoye; R Wiseman
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 3.  Inference in linkage analysis of multifactorial traits using recombinant inbred strains of mice.

Authors:  P E Neumann
Journal:  Behav Genet       Date:  1992-11       Impact factor: 2.805

Review 4.  The 5q- abnormality.

Authors:  S D Nimer; D W Golde
Journal:  Blood       Date:  1987-12       Impact factor: 22.113

5.  Two genetically transmitted BALB/c mouse mammary tumor virus genomes located on chromosomes 12 and 16.

Authors:  R Callahan; D Gallahan; C Kozak
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

6.  Cytogenetic study in multiple myeloma.

Authors:  A Ferti; A Panani; G Arapakis; S Raptis
Journal:  Cancer Genet Cytogenet       Date:  1984-07

7.  Mapping of murine interferon-alpha genes to chromosome 4.

Authors:  K A Kelley; C A Kozak; F Dandoy; F Sor; D Skup; J D Windass; J DeMaeyer-Guignard; P M Pitha; E DeMaeyer
Journal:  Gene       Date:  1983-12       Impact factor: 3.688

8.  Assignment of the genes encoding human interleukin-8 receptor types 1 and 2 and an interleukin-8 receptor pseudogene to chromosome 2q35.

Authors:  S W Morris; N Nelson; M B Valentine; D N Shapiro; A T Look; C J Kozlosky; M P Beckmann; D P Cerretti
Journal:  Genomics       Date:  1992-11       Impact factor: 5.736

9.  Sequence and organization of the mouse poly (ADP-ribose) polymerase gene.

Authors:  K Huppi; K Bhatia; D Siwarski; D Klinman; B Cherney; M Smulson
Journal:  Nucleic Acids Res       Date:  1989-05-11       Impact factor: 16.971

10.  Non-random chromosomal aberrations associated with multiple myeloma.

Authors:  J P Lewis; M R MacKenzie
Journal:  Hematol Oncol       Date:  1984 Oct-Dec       Impact factor: 5.271

View more
  27 in total

1.  Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5.

Authors:  Jessica Amlin-Van Schaick; Sungjin Kim; Karl W Broman; Karlyne M Reilly
Journal:  Mamm Genome       Date:  2011-12-08       Impact factor: 2.957

2.  Loci controlling lymphocyte production of interferon c after alloantigen stimulation in vitro and their co-localization with genes controlling lymphocyte infiltration of tumors and tumor susceptibility.

Authors:  Marie Lipoldová; Helena Havelková; Jana Badalova; Jarmila Vojtísková; Lei Quan; Magdaléna Krulova; Yahya Sohrabi; Alphons P Stassen; Peter Demant
Journal:  Cancer Immunol Immunother       Date:  2010-02       Impact factor: 6.968

3.  Genetic mapping of the human and mouse phospholipase C genes.

Authors:  M S Lyu; D J Park; S G Rhee; C A Kozak
Journal:  Mamm Genome       Date:  1996-07       Impact factor: 2.957

4.  Riz maps to distal chromosome 4 near genes involved in tumorigenesis and nerve degeneration.

Authors:  B A Mock; M P Coleman; S Huang
Journal:  Mamm Genome       Date:  1996-08       Impact factor: 2.957

5.  Generation and mapping of Mus spretus strain-specific markers for rapid genomic scanning.

Authors:  R Elango; L Riba; D Housman; K Hunter
Journal:  Mamm Genome       Date:  1996-05       Impact factor: 2.957

6.  Role of interleukin-6 in the pathogenesis of murine plasmacytoma and human multiple myeloma.

Authors:  P K Pattengale
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

7.  Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrained.

Authors:  Cassandra J Vandenberg; Paul Waring; Andreas Strasser; Suzanne Cory
Journal:  Blood       Date:  2014-07-01       Impact factor: 22.113

8.  The transcription factor MZF1 differentially regulates murine Mtor promoter variants linked to tumor susceptibility.

Authors:  Shuling Zhang; Wei Shi; Edward S Ramsay; Valery Bliskovsky; Adrian Max Eiden; Daniel Connors; Matthew Steinsaltz; Wendy DuBois; Beverly A Mock
Journal:  J Biol Chem       Date:  2019-09-23       Impact factor: 5.157

9.  QTL analyses of lineage-negative mouse bone marrow cells labeled with Sca-1 and c-Kit.

Authors:  Mays Jawad; Clare Cole; Abigail Zanker; George Giotopoulos; Simon Fitch; Christopher J Talbot; Mark Plumb
Journal:  Mamm Genome       Date:  2008-02-21       Impact factor: 2.957

10.  Multiple genetic loci modify susceptibility to plasmacytoma-related morbidity in E(mu)-v-abl transgenic mice.

Authors:  R C Andrew Symons; Mark J Daly; Jane Fridlyand; Terence P Speed; Wendy D Cook; Steven Gerondakis; Alan W Harris; Simon J Foote
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.